Maria Aurora Posadas Salas

Maria Aurora Posadas Salas

Auto-generated profile, based on publicly available information

Maria Aurora Posadas Salas

Medical University of South Carolina, Charleston, SC, United States

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2022 in Clinical Transplantation
Verified
Journal Article
Closed access
MSMaria Aurora Posadas Salas
Maria Aurora Posadas Salas
ECElizabeth Chua
Elizabeth Chua
ARAna Rossi
Ana Rossi
SSSilvi Shah
Silvi Shah
GKGoni Katz‐Greenberg
Goni Katz‐Greenberg
DADeborah Adey
Deborah Adey

1 January 2016 in World Journal of Transplantation
Verified
Journal Article
Open access
MKMahmoud Kamel
Mahmoud Kamel
MKManish Kadian
Manish Kadian
TSTitte Srinivas
Titte Srinivas
DTDavid Taber
David Taber
MSMaria Aurora Posadas Salas
Maria Aurora Posadas Salas
Tacrolimus confers lower acute rejection rates and better renal allograft survival compared to cyclosporine

9 September 2013 in Transplant Infectious Disease
Verified
Journal Article
Closed access
PDF file
MSM.A. Posadas Salas
M.A. Posadas Salas
DTD.J. Taber
D.J. Taber
ECE. Chua
E. Chua
NPN. Pilch
N. Pilch
KCK. Chavin
K. Chavin
BTB. Thomas
B. Thomas

1 September 2014 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
MSMaria Posadas Salas
Maria Posadas Salas
TSTitte Srinivas
Titte Srinivas
Adherence to immunosuppression and minimizing variability in drug exposure are important considerations in preventing rejection and maximizing overall transplant outcomes. The availability of once-daily tacrolimus may confer potential benefit by simplifying immunosuppressive regimens, thereby improving medication adherence among transplant recipients. Pharmacokinetic studies in healthy normal volunteers and stable transplant recipients suggest that once-daily tacrolimus is bioequivalent to twice-daily tacrolimus. Efficacy studies suggest that once-daily tacrolimus is noninferior to twice-daily tacrolimus with a concentration-dependent rejection risk. The incidence of biopsy-proven acute rejection, graft survival, and patient survival are more or less comparable between the two tacrolimus formulations. Once-daily tacrolimus has also been reported to have favorable effects on blood pressure, lipid profile, and glucose tolerance. Once-daily tacrolimus may be a viable option to consider for de novo immunosuppression or for conversion from conventional tacrolimus.

1 October 2021 in The American Journal of the Medical Sciences
Verified
Journal Article
Closed access
MMMahmoud Mohamed
Mahmoud Mohamed
KSKarim Soliman
Karim Soliman
RPRaghavesh Pullalarevu
Raghavesh Pullalarevu
MKMahmoud Kamel
Mahmoud Kamel
TSTitte Srinivas
Titte Srinivas
MSMaria Aurora Posadas Salas
Maria Aurora Posadas Salas

21 July 2020 in JMIR Formative Research
Verified
Journal Article
Open access
AWAmy D Waterman
Amy D Waterman
EWEmily Hayes Wood
Emily Hayes Wood
OROmesh N Ranasinghe
Omesh N Ranasinghe
ALAmanda Faye Lipsey
Amanda Faye Lipsey
CACrystal Anderson
Crystal Anderson
MSMaria Aurora Posadas Salas
Maria Aurora Posadas Salas
Background: It is not common for people to come across a living kidney donor, let alone consider whether they would ever donate a kidney themselves while they are alive. Narrative storytelling, the sharing of first-person narratives based on lived experience, may be an important way to improve education about living donor kidney transplants (LDKTs). Developing ways to easily standardize and disseminate diverse living donor stories using digital technology could inspire more people to consider becoming living donors and reduce the kidney shortage nationally. Objective: This paper aimed to describe the development of the Living Donation Storytelling Project, a web-based digital library of living donation narratives from multiple audiences using video capture technology. Specifically, we aimed to describe the theoretical foundation and development of the library, a protocol to capture diverse storytellers, the characteristics and experiences of participating storytellers, and the frequency with which any ethical concerns about the content being shared emerged. Methods: This study invited kidney transplant recipients who had received LDKTs, living donors, family members, and patients seeking LDKTs to record personal stories using video capture technology by answering a series of guided prompts on their computer or smartphone and answering questions about their filming experience. The digital software automatically spliced responses to open-ended prompts, creating a seamless story available for uploading to a web-based library and posting to social media. Each story was reviewed by a transplant professional for the disclosure of protected health information (PHI), pressuring others to donate, and medical inaccuracies. Disclosures were edited. Results: This study recruited diverse storytellers through social media, support groups, churches, and transplant programs. Of the 137 storytellers who completed the postsurvey, 105/137 (76.6%) were white and 99/137 (72.2%) were female. They spent 62.5 min, on average, recording their story, with a final median story length of 10 min (00:46 seconds to 32:16 min). A total of 94.8% (130/137) of storytellers were motivated by a desire to educate the public; 78.1% (107/137) were motivated to help more people become living donors; and 75.9% (104/137) were motivated to dispel myths. The ease of using the technology and telling their story varied, with the fear of being on film, emotional difficulty talking about their experiences, and some technological barriers being reported. PHI, most commonly surnames and transplant center names, was present in 62.9% (85/135) of stories and was edited out. Conclusions: With appropriate sensitivity to ensure diverse recruitment, ethical review of content, and support for storytellers, web-based storytelling platforms may be a cost-effective and convenient way to further engage patients and increase the curiosity of the public in learning more about the possibility of becoming living donors.